Diabetes Drugs Global Strategic Business Report 2024: Market to Surpass $205 Billion by 2030 - Development of GLP-1 Receptor Agonists Expands Treatment Options
September 27, 2024 09:19 ET
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Diabetes Drugs...
Global Insulin Pen Market Poised for Expansion, Projected to Reach US$ 10.71 Billion by 2032, Fueled by Technological Advancements and User-Friendly Designs and International Prevalence of Diabetes
July 24, 2024 11:16 ET
|
Research and Markets
Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market Report by Product, Disease types, Distribution Channels Regions and Company Analysis 2024-2032" report has been added to ...
Global Insulin Delivery Systems Strategic Research Report 2024-2030 - Constantly Expanding R&D Activities and New Pioneering Treatments Influence Growth
May 21, 2024 05:44 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Insulin Delivery Systems...
Response Scientific's Revolutionary New Biotech and Healthcare Products Will Affect the Lives of Millions
January 30, 2014 09:00 ET
|
Response Scientific, Inc.
PRINCETON, N.J., Jan. 30, 2014 (GLOBE NEWSWIRE) -- For over a decade Response Scientific, Inc.® has been at the forefront of biotechnology innovation. Response Scientific's renowned scientific...